331 related articles for article (PubMed ID: 18581039)
1. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
Beltramo E; Berrone E; Tarallo S; Porta M
Acta Diabetol; 2008 Sep; 45(3):131-41. PubMed ID: 18581039
[TBL] [Abstract][Full Text] [Related]
2. Could thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?
Alcázar-Leyva S; Alvarado-Vásquez N
Med Hypotheses; 2011 May; 76(5):629-31. PubMed ID: 21288652
[TBL] [Abstract][Full Text] [Related]
3. The multifaceted therapeutic potential of benfotiamine.
Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
[TBL] [Abstract][Full Text] [Related]
4. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro.
Schmid U; Stopper H; Heidland A; Schupp N
Diabetes Metab Res Rev; 2008; 24(5):371-7. PubMed ID: 18384109
[TBL] [Abstract][Full Text] [Related]
5. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hammes HP; Du X; Edelstein D; Taguchi T; Matsumura T; Ju Q; Lin J; Bierhaus A; Nawroth P; Hannak D; Neumaier M; Bergfeld R; Giardino I; Brownlee M
Nat Med; 2003 Mar; 9(3):294-9. PubMed ID: 12592403
[TBL] [Abstract][Full Text] [Related]
6. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine.
Beltramo E; Berrone E; Tarallo S; Porta M
Diabetes Metab Res Rev; 2009 Sep; 25(6):566-76. PubMed ID: 19593734
[TBL] [Abstract][Full Text] [Related]
7. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
Berrone E; Beltramo E; Solimine C; Ape AU; Porta M
J Biol Chem; 2006 Apr; 281(14):9307-13. PubMed ID: 16452468
[TBL] [Abstract][Full Text] [Related]
8. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.
Beltramo E; Berrone E; Buttiglieri S; Porta M
Diabetes Metab Res Rev; 2004; 20(4):330-6. PubMed ID: 15250036
[TBL] [Abstract][Full Text] [Related]
9. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy.
Rabbani N; Thornalley PJ
Diabetes Obes Metab; 2011 Jul; 13(7):577-83. PubMed ID: 21342411
[TBL] [Abstract][Full Text] [Related]
11. Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy.
Jonus HC; Byrnes CC; Kim J; Valle ML; Bartlett MG; Said HM; Zastre JA
Biomed Pharmacother; 2020 Jan; 121():109648. PubMed ID: 31810115
[TBL] [Abstract][Full Text] [Related]
12. Detection of transketolase in bone marrow-derived insulin-producing cells: benfotiamine enhances insulin synthesis and glucose metabolism.
Oh SH; Witek RP; Bae SH; Darwiche H; Jung Y; Pi L; Brown A; Petersen BE
Stem Cells Dev; 2009; 18(1):37-46. PubMed ID: 18393672
[TBL] [Abstract][Full Text] [Related]
13. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
Babaei-Jadidi R; Karachalias N; Ahmed N; Battah S; Thornalley PJ
Diabetes; 2003 Aug; 52(8):2110-20. PubMed ID: 12882930
[TBL] [Abstract][Full Text] [Related]
14. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose.
Pomero F; Molinar Min A; La Selva M; Allione A; Molinatti GM; Porta M
Acta Diabetol; 2001; 38(3):135-8. PubMed ID: 11827434
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].
Małecka SA; Poprawski K; Bilski B
Wiad Lek; 2006; 59(5-6):383-7. PubMed ID: 17017487
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro.
Thornalley PJ; Jahan I; Ng R
J Biochem; 2001 Apr; 129(4):543-9. PubMed ID: 11275553
[TBL] [Abstract][Full Text] [Related]
17. The potential role of thiamine (vitamin B1) in diabetic complications.
Thornalley PJ
Curr Diabetes Rev; 2005 Aug; 1(3):287-98. PubMed ID: 18220605
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of benfotiamine and its molecular targets.
Raj V; Ojha S; Howarth FC; Belur PD; Subramanya SB
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3261-3273. PubMed ID: 29863274
[TBL] [Abstract][Full Text] [Related]
19. Thiamine supplementation to cancer patients: a double edged sword.
Boros LG; Brandes JL; Lee WN; Cascante M; Puigjaner J; Revesz E; Bray TM; Schirmer WJ; Melvin WS
Anticancer Res; 1998; 18(1B):595-602. PubMed ID: 9568183
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors.
Thomas AA; Le Huerou Y; De Meese J; Gunawardana I; Kaplan T; Romoff TT; Gonzales SS; Condroski K; Boyd SA; Ballard J; Bernat B; DeWolf W; Han M; Lee P; Lemieux C; Pedersen R; Pheneger J; Poch G; Smith D; Sullivan F; Weiler S; Wright SK; Lin J; Brandhuber B; Vigers G
Bioorg Med Chem Lett; 2008 Mar; 18(6):2206-10. PubMed ID: 18267359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
